Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Japan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20071
20091
20102
20121
20163
20173
20186
20211
20221
20232
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Active, not recruiting7
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
AstraZeneca3
Merck Sharp & Dohme LLC3
AbbVie2
Amgen2
Genmab2
Pfizer2
Takeda2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms32
Ovarian Neoplasms27
Carcinoma, Ovarian Epithelial9
Peritoneal Neoplasms5
Brenner Tumor3
Neoplasms3
Triple Negative Breast Neoplasms3
Breast Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma, Clear Cell1

Trials

Showing 51 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.